Question Time - Morning Session
Q1
|
An important aspect of people haemodialysing is the machines
that keep you alive, and the very important technicians who maintain
them. I had a worrying conversation with one from Barts in London
who is shortly to retire and the fact there won’t be many technicians
to maintain these machines. I don’t know what it’s like in the rest
of the country. Is anybody looking at the availability of technicians,
who get paid relatively low amounts of money for the highly skilled
work they do. Is there a problem? |
A
|
Polly Moseley: From the home haemodialysis perspective, the
technicians are absolutely crucial. They are on call and we do
call them out. I would have nothing like the quality of life without
the home haemodialysis and the technicians. We do have enough
of them in Newcastle, but they don’t all work over the weekends.
Professor Feest: We’ve got a lot of data about technicians
from 1998 and we will be repeating the review next year. In general
recruitment of technicians isn’t a big problem. And there’s certainly
no intention that it should be wound down.
|
Q2
|
There’s a lot of controversy at the moment around paying for
donors and I appreciate that, for example, when we talk about illegal
donations often there’s reference to donors going to say India where
the standard of surgery appears to be defective in many ways and
also the risks to the actual donors are quite high as well. But while
I appreciate it’s very emotional, and I know it’s not a straightforward
question, I wonder what is the risk to the donors if the operation
is performed at what we would consider to be of a good standard? |
A
|
Hany Riad: The risk of live kidney donation to the donor is
quite small. Every donor when they come to be assessed, they obviously
have explained to them the risk of haemorrhaging and infection. We
also explain that the risk of death as a result of the operation
is extremely small, in the region of one in four or five thousand,
if not less. There are advances in live kidney donation surgical
procedures, and you have probably heard of keyhole surgery which
is now being done mainly in two centres and is expanding. Surgeons
seem to differ in their attitudes towards keyhole surgery, but
it is expanding. As soon as people do it comfortably, it is a
safe procedure.
As far as paying for donors, there are two issues here:
1. One is paying for loss of earnings
and expenses and this is supported by the Department of Health. However,
the guidance from the Department of Health seems to be, they encourage
it, they support it but they never put pressure on the purchaser
and health authorities to actually do it, and I have a case of
a mother who is asking for £100, and the health authority is refusing
to pay it. The guidance from the Department again is not forceful
in pressurising the health authorities to pay it, and this is wrong.
2. Now, do you pay for donors actually
to donate an organ? Are you going to put a price on the kidney? This
is a totally different matter. If you want to be controversial,
you can say that there is nothing wrong with selling an organ,
but what’s probably wrong is buying it. It’s a big debate which
will be entered into some time in the future.
Professor Feest: You might watch when the NSF comes out. It is
likely that there will be very clear guidance that the costs of
donors should be reimbursed. A lot of them are reimbursed anyway. There
is universal agreement that loss of earnings should be reimbursed.
I think that will happen much more easily.
|
Q3
|
Richard Moore, Cardiff: The increasing gap between demand
and supply of cadaver organs means that we need to look not
just at the quantity but also the quality. You indicated that
we were better drivers than the Spanish. It means our donors are
becoming older, with increased risk of other medical conditions.
I’m concerned at the time of donation, many ITUs tend to switch
off because in terms of looking after the donor, because they’re
brain stem dead, their blood pressure drops, they’re not optimally
hydrated. Your title is director of donor care and co-ordination,
so I assume there might be a move by UKT to look at organ procurement
teams which will maximise the state of donors at the time of donation. Is
that so?
|
A
|
Sue Falvey: Yes, it is so. We have put together two working
groups who hopefully will be meeting in November or December. One
is to look at the organ retrieval process in its entirety, and
clearly even now some teams struggle if they have two donors in
their local location, and if we hope to increase the donor rate,
we need to ensure that we have the resources in place and the appropriately
trained people in place to ensure that retrieval takes place efficiently
and quickly, which is what the donor’s family want and the intensive
care unit want. For one thing they may have pressure on beds and
clearly it is better for the organs if you can retrieve them as
quickly as possible, because they will begin to deteriorate the
longer the patient is ventilated.
And we also have a second working group which is looking at donor
management, because there is no doubt about it, organs are lost
through poor donor management, particularly hearts and lungs.
|
Q4
|
Maurice Johnston, Humberside: Miss Steele, the needle one,
is it longer than 20 minutes? I was a CAPD patient. |
A
|
Maggi Steele: The actual procedure itself from start to
finish is probably only two or three minutes longer. It obviously
depends
on the individual, but the speed in which it flows in and out is
exactly the same as in a standard procedure. There’s probably a
few more packets that the patient has to open, and donning the sterile
gloves, but we’re only talking two or three more minutes difference.
|
Q5
|
Goole, Birmingham: We are all worried about the waiting lists
going up. Opting out is a problem. In Spain you said they were better. But
if people have to opt in, they can carry the card. If people can
just be used for donation, if they don’t want to donate, then they
can carry a card. If there is no card carried, why can’t they be
used for transplants? |
A
|
Lilian Rutherford: It’s the relatives, the living people we
have to care for. We’re very concerned. I used to be a member
of BODY who are donor families, who have experienced donation,
and the nurses and doctors have to deal with the living, and I
know donor families, and I would hate to think we took an organ
and a family took years and years to come to terms with that, if
they ever did. I would rather die than get a kidney that was not
a gift of life. OK, the donor may have wanted to give it, but
if they did not communicate it, I’d find that very hard to live
with.
I think we have to look after the living once we know we’ve
got a donor there, and it’s ideal if people do want to donate. I
had a cousin who ended up on the streets of Edinburgh from having
children at a private school, a very good business, turned an alcoholic
and ended up on the streets of Edinburgh. If he didn’t want to
donate, I would have hated for someone to take his organs, if he
didn’t know about the opting out system. For me, it’s peace of
mind and for the nurses I work with it’s peace of mind as well. Because
I look after people after a kidney patient has died, I still see
my relatives, because I work in the community. I used to be selfish,
and I still am in some respects, but I think in this you have to
look after the people who are living.
Hany Riad: I very much agree with what’s been said. A scenario
which we come across not infrequently is of an 18 year-old who
comes off his motorbike and has a serious head injury. If this
person had not opted out and if the mother say I don’t want my
son’s organs to be removed, would you still want me to take his
organs out against his mother’s request? For that’s what opting
out means.
Professor Feest: It’s a convenient debate – it has been
in the past – to get everyone arguing about opting out and opting
in while they’re not looking at getting money into other areas
that are proven to work. I think things have changed through UKT,
but there are a lot of other areas that are going to make much
more difference
than opting in or opting out. I think the politicians have got
you comfortably talking about something that probably won’t make
much difference and isn’t politically such a hot potato as some
of the other things, like interventional ventilation and things
like that. Huge numbers of the population actually do not put
their names on registers either way. There is a huge inertia,
and families have views. I would be very uncomfortable taking
kidneys from and 18 or an 80 year old if the family was saying
I don’t want you to do it. I personally couldn’t do that.
Maggi Steele: An important point is that if your family
know what your wishes are in the event of your death, even if it
is not what
they would want, the chances of them going against your wishes
are remote. And in fact the first donor family I ever saw back
in 1985 was the mother of a 16 year-old who died from a head injury
and that was in the days of the 'That’s Life' television programme,
and she actually said to me “I hate everything about this, I do
not want to do this, but last week, he watched something on the
television,
he told
me, if anything ever happens to me that’s what I want, because
what a waste if it didn’t.” And she said, therefore I have to
do it, and if there were a small number of families to whom you
would cause so much distress if you went ahead and they didn’t
want you to do it, potentially the negative publicity that that
may generate could damage donation programmes much more than actually
losing a very small percentage of families who may not fulfil their
relative’s wishes, which is why it’s so important that the message
is that everyone must make sure that their nearest and dearest
know what they want in the event of their death.
|
Q6
|
John Blanchard, Humberside: I would willingly give one of
my kidneys to my wife but the biggest stumbling block is who do I
approach to sort it out. I’ve asked her consultant and yes, he’s
willing, but I’m still waiting. I don’t even know if he’s put me
forward for the tests. Who is the best person? Also I do feel that
if my kidney is not suitable for my wife, I should have the right
to donate my kidney to anybody else on the waiting list who needs
it. I don’ want payment for it. I would give a kidney to my wife – I’d
give it to anyone who needs it/ Why can’t I? |
A
|
Hany Riad: Two things – one is if you’re wife’s nephrologist
is prevaricating a bit about considering you as a potential donor
for your wife, go to the transplant surgeon. Surgeons seem to get
things moving quicker than physicians – sometimes. The issue about
the swap of kidneys has been raised. I recently had a letter from
a family who wants the same thing. It needs a lot of organisation. It’s
not impossible, but you have to do it at the exact same thing and
if you are identified in your own unit, you and your wife, and
another couple somewhere else, suppose you donate your kidney and
the other person in the other unit decided not to. It’s something
that in theory it can work, probably in practice it might work
but it needs a hell of a lot of organisation and looking into.
Professor Feest: We actually tried this – we had two couples who
wanted to do this and we would have operated at the same time. But
we were refused permission by the ULTRA regulations. They said
at the moment they wouldn’t touch it. So there are people willing
to try it, but I think the timing is critical. In terms of giving
a kidney to your wife, if you lived where we live, you wouldn’t
be sitting in that seat now.
Lilian Rutherford: I think we’re back where we were in the 70s
and early 80s, where it wasn’t even allowed for wives and husbands
and husbands and wives to give kidneys. We have moved on from
there. I think Newcastle and Dr Ross Taylor brought that one forward
as far as I am aware as a patient. I think it was on the Kilroy
programme that Ross brought forward a couple where I think the
wife had given the husband a kidney. Who knows, we might be hearing
in five or ten years time and you’ve donated to a friend or another
kidney patient. And as far as getting your live donor to your
wife up and running, I would see the transplant co-ordinator. Or
are you in one of these unfortunate areas that doesn’t have a transplant
co-ordinator? You may have to go to Middlesbrough or Newcastle,
I don’t know.
John Blanchard: We do have a transplant co-ordinator, but I’ve
yet to be able to see them.
Professor Feest: You’re all talking about wife to husband, husband
to wife. You don’t have to be a married partner or a married friend
to donate, and we certainly have had one or two donations simply
from long-standing friends, not partners, but long-standing friends. If
you can prove that it is a long-standing friendship and I think
that’s reasonable because otherwise there is a grave danger of
paid or coercion donors. It could be someone who is a lifelong
friend who donates.
|
Q7
|
Helen Lewis: I am a speaker this afternoon on community care. I’ve
a question about dialysis for Maggi Steele. For patients where dialysis
is the treatment of choice, for various reasons, we were really interested
in the new Life Site device for APD and wonder about other studies
and how quickly it was going to be available for patients in the
UK, if your trials were successful. So perhaps some information
about the trials that have taken place in the States, where it has
been used for peritoneal dialysis in the States and whether other
centres in this country are going to gain access and how soon, depending
on the results. |
A
|
Maggi Steele: I am not aware that there are in fact any other studies
in the world taking place. We are the first centre to be conducting
a clinical study. It does have marketing approval in Europe. It
has the CE mark. As yet it has not undergone FDA approval over in
America, unlike the Life Site device for haemodialysis access. But
that was given FDA approval about two years ago, I believe, and hence
the patient numbers are above 5,000 for haemodialysis. But for PD,
we’re talking extremely early days, and there is no other experience. We’re
the first centre. We are on a massive learning curve. We’ll just
have to wait and see but ultimately to give good comparative figures,
the company will need to roll out the experience but in the first
instance they are looking for initial results from our small study.
|
Q8
|
Polly Mosely: if we’re going to move forward and transplant
more people, we’re going to have to look further than live related
transplants or cadaver transplants. We need to look at the other
things that are open to us. We talked about pigs. I know it’s a
very emotive subject but somebody mentioned on the panel something
about people are hi-jacking whole agendas, well, animal liberationists
are hi-jacking the agenda of using perhaps pigs’ kidneys. It may
be five, then, 15 years down the line but we need to be maximising
our lives by looking at other options and we need to be standing
up and we need to be saying people are suffering and we are not going
to be dictated to by people who in my experience sometimes have never
even had ‘flu. It’s very easy to stand on the high ground and say,
that’s wrong, if you are a very healthy person. |
A
|
David Griffen: Would the panel like to respond?
Professor Feest: I agree with you, but it isn’t actually the animal
liberation movement that is stopping pigs kidneys, it’s problems
with safety and whether it can actually be done. At the moment
it doesn’t work. So research is continuing. The other issue is
that we do need to keep pressing on with cadaver and live transplants
because if you look at Spain which has the high treatment rates
for renal failure they actually have more kidneys than they need. Now
it’s the only country that has managed it. Spain do not do live
donor transplants, or very rarely, because they have got so many
cadaver grafts. There are a lot of problems and they do have bad
drivers, but we could do a lot better if the organisation was different. It’s
not in the renal units we have to look, it’s in the rest of the
hospitals that we have to be working. Opting out or opting in
won’t make any difference. The difference is in the way hospitals
are organised. That’s where we have to look.
Lilian Rutherford: I think we also have to go back to prevention. OK,
it can’t change my life, it can’t change your life. We have had
to live with it and we still have to live with it. But we have
to look at the children, the Asian people that I’ve nursed. They
come in with blood pressures. Yesterday I had an Asian chap who
was a doorman and he’s been taking steroids and I said to him “What
are you playing at?” He had an HB of 19 point something and he’s
going into renal failure. But he said, “I’ve got to look like
this to stand at the doors of the night club.” I told him, “Well,
you are a fool,” because I speak straight to patients. And they
take it or if they don’t I explain why I speak like that. Once
they know my background it makes them think twice. OK, I look
well and healthy and I work full time but it’s been hard, as Polly
said, every day is a fight. I’ve done it for 30 odd years, I know.
So my main theme is prevention. We can’t change what we’ve got
but we can change the future by hopefully not getting more people
in this special club that we are in today.
Polly Mosely: Can I just say I agree with you? Obviously you
want to look at the best options for transplants but I had a transplant
six years ago and it lasted three months and I’m not on the list
at the moment. I think when people have been successfully transplanted
and received this gift of life, it’s quite easy to look back and
see the time of life that you were on dialysis as a write-off.
That’s really difficult for people who are on long-term dialysis
to deal with because they think that my life is a write-off until
I get a transplant. They have got this kind of Holy Grail view
of what a transplant is that it’s going to solve all their problems
in life. And that makes dealing with transplant failure so much
more difficult when it happens. Then you have to go through the
trauma of readapting as though your whole life is back to square
one. There’s so much that can be done to improve patient quality
of life on dialysis, not only through treatment but through the
other areas of their life that they are able to engage in and live
life much more to the full than a lot of people feel able to do. It’s
quite a difficult tension to manage here for the National Kidney
Federation, because yes, you want to promote transplantation, but
not at the expense of people’s lives who are on dialysis just as
a waiting game, because there’s a lot you can achieve in terms
of a career and a full life on dialysis.
|
Question Time - Afternoon session
Q9 |
Thomas Hoxhale, Liverpool: You were talking about the invalid care
allowance, saying that anyone could get it. Am I right in saying that
at the end of this month the invalid care allowance for anyone over 65
years of age will stop as a carer, unless you’re means tested once you
start drawing your pension at 65? |
A |
Jane Atha: I know that changes, when it becomes the carers’ allowance,
that you can claim it if you are over 65.
Thomas Hoxhale: In the new legislation that has just come out, anyone
over 65 the invalid care allowance ceases once you pick up your pension. Is
there any reason for this, because my wife has been on home dialysis
for 28 years now and I still have the care of her which will go on, obviously,
but the benefit will cease when I’m 65.
Jane Atha: I know that your pension is taken into account when claiming
invalid care allowance. You can now claim invalid care allowance when
you’re over 65, but you may not get it because of your pension entitlement. Like
I was saying earlier about benefits being a minefield.
Thomas Hoxhale: Is the Government saying that my wife’s care ceases
when I’m 65? I still have the same responsibilities. I mean other people
will get their old age pension at 65, and I gave up work when I was 58
to look after my wife. Is there anything being done about it by yourselves?
Jane Atha: I don’t know the finer details.
Simon Wall, renal social worker: On the invalid care allowance, the
rules change from October 28, tomorrow. Previously, if you were over
65, you couldn’t claim any invalid care allowance or carers’ benefit,
so the actual change in what the Government are doing, even though it’s
only a notional claim and it’s means tested, through social workers and
patients lobbying the Government to change the rules, it is acknowledging
the fact that people over 65 are caring for people. It’s a small step
towards recognising it even further, so if you were over 65 before when
you were a carer there was no recognition of that. You wouldn’t get
any benefit or any entitlement, so the way they’ve changed it now is
that, yes, your pension is taken into account and it is means tested,
but it is a small step towards the recognition of it. So before tomorrow,
anyone over 65 – you may be putting in 35 hours care, you may be putting
in 70 hours care, the Government wouldn’t recognise that at all. So
in a small way it’s a very small step, and a very small positive step.
But before Monday if you were over 65, no benefits, no recognition of
your care. We all know the ageing population is growing vastly and it’s
a recognition towards the value of carers to the Government. A £101m
worth of caring in Middlesbrough alone shows a great vastness.
|
Q10
|
Julie King, Addenbrookes: You talked about when your daughter changed
hospitals. Is this not something that the NKF could take up? It is pretty
traumatic when you change from being a paediatric to being an adult, and
all the hospitals seem to vary in how they do this and their protocols. Is
this something the NKF could look at, maybe do a questionnaire, and follow
it through and then set out the procedure and how it’s best done? |
A |
Gary Lloyd: This is something that the NKF has become aware
of, the problem with paediatric care. We have now, with the help of
Sara Tyler, started off the Young Persons Group, and it will be looked
into in the
future.
Anne Keogh: I’d just like to add the comment that of course the National
Service Framework isn’t going to solve all the problems but I think the
NKF is lobbying as a group and a lot of people are speaking with the
collective voice. But you all have a voice as well. Go on to the Department
of Health website. The NSF details are there and you can add your comments
as an individual, so the transition from paediatric to adult care is
a good example. The more voices that are heard out there the more people
will listen.
Helen Lewis: Another point here is that many patients’ organisations
use some of their funding for social research into this area and look
in depth at young people’s voices in a structured sort of way. If that
report is published, it can be used by organisations to lobby Government,
lobby health services, and get more publicity. It’s not only patients’ groups
but also actually social research and the weight, if you like, of academic
research can actually add value to getting changes.
Simon Lloyd: Can I just add something else about NSFs and what we expect
from them? When the first one came through on the elderly, they promised
the earth. They delivered so little money that very little has happened. And
I think we have got to be very careful, and I hear what people are saying
about the NSF, it’s the target that will eventually, hopefully, mature
in probably about ten years’ time. We ain’t going to get it today. The
money ain’t there. This is a difficult one. I happened to have been
the observer on Northumberland Healthcare Trust which has a multi-million
budget, and for the NSF for the elderly in a great big area the Government
gave £40,000. Peanuts. And this is the amount the Government at the
moment cares. I’m glad the Framework is coming into being, I think it
will take a long time.
Sara Tyler: I’d just like to add about paediatric care to adult
unit. There
was a very useful conference on this topic this summer at Hope Hospital
in Manchester and it was called Toddlers to Twenties, and it specifically
looked at non-compliance in terms of transplanted patients who were transferred
from paediatric to adult services. There was a patient there who spoke
who had lost his transplant after becoming non-compliant after moving
to adult services. There was some very useful talks and some research
that came out at that conference, so I’m sure that the people from Hope
Hospital would be happy to disseminate some of that information, which
could maybe kick start some of the further research that could go on
nationally. Because I think it’s a very crucial area that Helen brought
up that hasn’t really been explored. The Toddlers to Twenties was in
June in Manchester and Donal O’Donohue, who was on the NSF group, was
the guy who was leading on that in Manchester.
Gary Lloyd: Thank you, we’ll look into that one.
|
Q11 |
Noel Beattie, Kent KPA: I tried to go on holiday with my suitcase,
as Helen Lewis described, and had the same kind of experiences with it. It’s
a very strenuous exercise doing that. Later on when I went onto haemo,
and working full time, and trying to go on a work conferences and so on,
I find that I cannot do it, I cannot move around the country freely, and
yet the medics say is, what we want you to do is to have a normal life. But
it isn’t there for us to have a normal life. And I’ve written to the Department
of Health about it and the reply comes back – more money is being put into
the service, but as we hear today, of course that’s needed for patients
who are coming on all the time. There is no money set aside for freeing
up spaces for holiday and work-related dialysis. Is there anything in
the Framework going to address that? |
A |
Anne Keogh: I can’t tell you specifically whether there is anything going
on, and I think what’s quite sad is that a very similar question was asked
last year at conference. Holidays are a major issue. All patients’ families
and staff would like to encourage holidays but the difficulty is the amount
of capacity, especially for haemodialysis up and down the country. Unless
we get more funding, there isn’t going to be. Every unit is working almost
to capacity for haemodialysis. What will be interesting is that the National
Institute for Clinical Excellence have now said that home haemodialysis
should be encouraged much more, but again that’s going to take quite a
long time in terms of freeing up spaces. I’m afraid there’s no good answer
to give you at the moment, but it is an area I know the politicians are
well aware of.
|
Q12 |
Mike Dowdle, North East KPA: Dr Chu, earlier you said, if I’m right,
that people who had skin cancer wouldn’t be given a second transplant.
Is that right, and also would that become widespread throughout the country? |
A |
Dr Chu: Certainly in our own hospital the renal transplant people see
a skin cancer as being a reason to refuse a second transplant. Now obviously
when you come off your immunosuppression, if you have a failed kidney,
and you go back on to dialysis, your risk goes down, you often are then
clear, and I believe that if you are then clear for a period of time then
they’ll reconsider. But certainly in the acute phases if you have a skin
cancer then they will not consider you for a second transplant at that
stage. I don’t know how widespread that is, that’s just locally within
the Hammersmith Hospital. It reflects possibly the fact that we’ve had
transplants going for a large number of years – we’ve got transplants that
are 20 years on – and a large number who have developed skin cancers and
have had problems with them.
|
Q13 |
Elizabeth Taylor, Llanclwyd KPA: You talked a lot today about the
Health Authority’s initiatives, which sound very good. But I’d just like
to know, does this include Wales? Wales is a different entity from England,
and when you talk about Health Authority you’re talking about London, Kent,
Birmingham, the Midlands, up north, Middlesbrough – nobody has mentioned
Wales. Can anybody give me anything on that? |
A |
Gary Lloyd: We don’t seem to have an answer at the moment. We will
look into that one and come back to you.
Guy Hill, North West KPA: Just to answer that lady (it wasn’t what I
was going to say) in fact there’s a question forward at the committee
meeting tomorrow with regard to Wales, because of the closure of some
form of combining a Welsh facility with Bristol. So there is something
we could say about Wales.
The point that was made earlier about the travel on haemodialysis. This
is something that we’ve looked at as a KPA, because we represent Manchester
where you would feel that lots of people would want to travel for longer
than the proverbial one dialysis night. I did approach our hospital
and ask them whether they would allow us to somehow fund a holiday/dialysis
situation, where we in fact paid for the bill for that particular stay. It
would be done with other KPAs – Newcastle, London, and that sort of scenario. I
think it’s within the NKF to try and arrange that sort of situation,
because it shouldn’t happen all the time. I was told that they had never
considered it because they had never been asked for it. And the question
I ask of all of us here is, whether if it was offered as some sort of
arrangement where you could have that sort of thing, would we actually
use it? Are there people who do want to travel for longer than the one
night? And therefore shouldn’t we have a reciprocal arrangement between
KPAs who could fund it? And maybe we could get sponsorship through one
of the companies represented outside to fund this service.
Simon Lloyd: I think the whole question of dialysis in different units
is a very difficult one. I have a sister on haemodialysis who finds
it difficult because she has a daughter in Aberystwyth. Because she
is on home haemo getting the tests and so on is difficult. Having said
that, I know that, having sat on our own regional special commissioning
group, there are ways of cost exchanging. I would caution against KPAs
getting involved in expenditure. The Health Authorities will pay for
it. They have done it and they will do it. There is a very real problem
in holiday dialysis. Can I say respectfully – some of it we have got
to be prepared to raise ourselves. How many of you are involved in a
user group in your hospital? Right, but not many. Look – there is recruitment
and people are crying out for people like us to get involved. Yes, you
won’t go in as a kidney patient, you will go in to represent the general
public. But you and I have a story to tell, and if we don’t tell it,
nobody else will, because from my experience people do not understand
our needs. They don’t even know that we need haemodialysis three times
a week. They don’t understand that there’s a difference between haemo
and peritoneal. Why aren’t we telling them? I know we’re busy with
our own things. But sometimes we need to actually invest some time in
getting involved. Katherine (Wright) and I are both involved in local
community health groups.
|
Q14 |
Judith Sidaway, Wordsley KPA: I’d just like to ask Tony Chu – if
patients take your words to heart and don’t go out in the sun at all,
use sunblock all the time, cover themselves up, what implications does
it have for the bones, the skeletal structure in the body?
|
A |
Tony Chu: Really very little. Even with a high factor sunblock.
How
many of you realise that you can get your sunblocks on prescription? You
don’t need to go and buy them. You can get Roc Factor 60 on prescription.
So go and ask your GP about it. Even using that you still get enough
ultra-violet through the skin to stimulate vitamin D, so you don’t get
rickets, there is no problem with that. There is still enough sun exposure. You
can’t completely exclude sun exposure from the body unless you actually
have a nocturnal lifestyle. But no risk there at all.
Gary Lloyd: I’d like to thank the panel. I’d like to thank you for
your questions. |
(Click here to go back to the summary page for this speech).
|